GENPHARMASEC
|
GENPHARMASEC Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹1.88 Cr | ₹0.25 Cr | ₹0.28 Cr |
| Adjustment | ₹-1.04 Cr | ₹0.39 Cr | ₹0.16 Cr |
| Changes In working Capital | ₹2.22 Cr | ₹-3.54 Cr | ₹-3.77 Cr |
| Cash Flow after changes in Working Capital | ₹3.06 Cr | ₹-2.90 Cr | ₹-3.32 Cr |
| Cash Flow from Operating Activities | ₹2.99 Cr | ₹-2.95 Cr | ₹-3.06 Cr |
| Cash Flow from Investing Activities | ₹-15 Cr | ₹-28 Cr | ₹0.36 Cr |
| Cash Flow from Financing Activities | ₹-1.25 Cr | ₹48 Cr | ₹3.08 Cr |
| Net Cash Inflow / Outflow | ₹-14 Cr | ₹17 Cr | ₹0.39 Cr |
| Opening Cash & Cash Equivalents | ₹19 Cr | ₹1.99 Cr | ₹1.61 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹5.27 Cr | ₹19 Cr | ₹1.99 Cr |
Compare Cashflow Statement of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹59.2 Cr | 17.6% | -9.3% | -52.3% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹5,997.7 Cr | -3.2% | -13.1% | -20.7% | Stock Analytics | |
| KIRI INDUSTRIES | ₹2,252.4 Cr | -0.1% | -17% | -42% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,573.3 Cr | 12.2% | 1.6% | -30% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,003.9 Cr | -0.7% | -2.1% | 13.9% | Stock Analytics | |
| BODAL CHEMICALS | ₹694.1 Cr | -3.5% | 17.6% | -11.8% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | 17.6% |
-9.3% |
-52.3% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses